Centre for Organ Transplantation

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


548 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ...
 
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P.W., Hoessly L.D., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al. American journal of transplantation. Peer-reviewed.
 
Infections respiratoires : quand un cheval est en fait un zèbre [Respiratory infections: when a horse is actually a zebra]
Cancela Costa A., Cobuccio L., Monsalve L., Pallanza M., Teixeira Antunes A., Manuel O., Desgranges F., 2024/04/10. Revue medicale suisse, 20 (869) pp. 734-738. Peer-reviewed.
 
Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH-ESOT survey.
Visentin A., Pickavance E., San-Juan R., Grossi P.A., Manuel O., Aguado J.M., 2024/04. Transplant infectious disease, 26 (2) pp. e14252. Peer-reviewed.
 
Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?
Kusejko K., Neofytos D., van Delden C., Hirsch H.H., Meylan P., Boggian K., Hirzel C., Garzoni C., Sidler D., Schnyder A. et al., 2024/03. Open forum infectious diseases, 11 (3) pp. ofae055. Peer-reviewed.
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial).
Mombelli M., Neofytos D., Huynh-Do U., Sánchez-Céspedes J., Stampf S., Golshayan D., Dahdal S., Stirnimann G., Schnyder A., Garzoni C. et al., 2024/01/25. Clinical infectious diseases, 78 (1) pp. 48-56. Peer-reviewed.
 
Gastroentérologie et hépatologie: ce qui a changé en 2023 [Gastroenterology and hepatology: what's new in 2023]
Fraga M., Wakim El-Khoury J., Oumrani S., Godat S., Vionnet J., Schoepfer A., Vieira Barbosa J., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 42-46. Peer-reviewed.
A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report.
Favrod-Coune T., Lidsky D., Vionnet J., Magini G., Déglon J., Broers B., 2024. Frontiers in medicine, 11 p. 1363012. Peer-reviewed.
 
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species.
Brune J.E., Dickenmann M., Sidler D., Walti L.N., Golshayan D., Manuel O., Haidar F., Neofytos D., Schnyder A., Boggian K. et al., 2024. Frontiers in medicine, 11 p. 1329778. Peer-reviewed.
Pre-transplant donor specific antibodies in ABO incompatible kidney transplantation - data from the Swiss transplant cohort study.
Deng Y., Frischnknecht L., Wehmeier C., de Rougemont O., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2024. Frontiers in immunology, 15 p. 1355128. Peer-reviewed.
 
Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.
Appenzeller-Herzog C., Rosat A., Mathes T., Baroja-Mazo A., Chruscinski A., Feng S., Herrero I., Londono M.C., Mazariegos G., Ohe H. et al., 2024/01. Liver international, 44 (1) pp. 250-262. Peer-reviewed.
Post-transplant survival with pre-transplant durable continuous-flow mechanical circulatory support in a Swiss cohort of heart transplant recipients.
Hullin R., Abdurashidova T., Pitta-Gros B., Schukraft S., Rancati V., Lu H., Zurbuchen A., Marcucci C., Ltaief Z., Lefol K. et al., 2023/12/04. Swiss medical weekly, 153 p. 3500. Peer-reviewed.
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/11. Open forum infectious diseases, 10 (11) pp. ofad536. Peer-reviewed.
 
Burden of seasonal influenza in the Swiss adult population during the 2016/2017-2018/2019 influenza seasons.
Ammann D., Bilger J., Loiacono M.M., Oberle S.G., Dounas A., Manuel O., Pletscher M., 2023/11. Influenza and other respiratory viruses, 17 (11) pp. e13218. Peer-reviewed.
Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
Kampouri E., Little J.S., Rejeski K., Manuel O., Hammond S.P., Hill J.A., 2023/11. Transplant infectious disease, 25 (Suppl 1) pp. e14157. Peer-reviewed.
Sodium Hydrosulfide Treatment During Porcine Kidney Ex Vivo Perfusion and Transplantation.
Agius T., Songeon J., Lyon A., Longchamp J., Ruttimann R., Allagnat F., Déglise S., Corpataux J.M., Golshayan D., Buhler L. et al., 2023/11. Transplantation direct, 9 (11) pp. e1508. Peer-reviewed.
 
Targeting the Complement Pathway in Kidney Transplantation.
Golshayan D., Schwotzer N., Fakhouri F., Zuber J., 2023/11/01. Journal of the American Society of Nephrology, 34 (11) pp. 1776-1792. Peer-reviewed.
Impact of COVID-19 on long-term lung function in lung transplant recipients: A single-center retrospective cohort study.
Touilloux B., Papadimitriou-Olivgeris M., Bongard C., Mansouri N., Ioakeim F., Manuel O., Koutsokera A., Aubert J.D., Casutt A., 2023/10. Transplant infectious disease, 25 (5) pp. e14151. Peer-reviewed.
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians.
Casutt A., Lamoth F., Lortholary O., Prior J.O., Tonglet A., Manuel O., Bergeron A., Beigelman-Aubry C., 2023/09/30. European respiratory review, 32 (169). Peer-reviewed.
 
Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
Born T., Vassallo P., Golshayan D., Di Liberto G., Brouland J.P., Egervari K., Merkler D., Du Pasquier R.A., Bernard-Valnet R., 2023/09/26. Neurology, 101 (13) pp. e1382-e1386. Peer-reviewed.
 
'Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply.
Manuel O., van den Bogaart L., Mueller N.J., Neofytos D., 2023/09. Clinical microbiology and infection, 29 (9) p. 1204. Peer-reviewed.
Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure.
Mangana Del Rio T., Sacleux S.C., Vionnet J., Ichaï P., Denys A., Schneider A., Coilly A., Fraga M., Wetzel A., Koerfer J. et al., 2023/08. JHEP reports, 5 (8) p. 100758. Peer-reviewed.
 
Which trial do we need? Culture of preservation fluid in abdominal organ transplant recipients.
Manuel O., van den Bogaart L., Mueller N.J., Neofytos D., 2023/07. Clinical microbiology and infection, 29 (7) pp. 832-834. Peer-reviewed.
 
Prise en charge des maladies rénales génétiques : expérience locale et importance du réseau [Management of genetic renal disorders: local experience and importance of the network]
Bonny O., Ketterer A., Hermida S., Superti-Furga A., Venetz J.P., Chehade H., Fodstad H., Cina V., Parvex P., Paoloni-Giacobino A. et al., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1245-1249. Peer-reviewed.
Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update.
Neofytos D., Stampf S., Hoessly L.D., D'Asaro M., Tang G.N., Boggian K., Hirzel C., Khanna N., Manuel O., Mueller N.J. et al., 2023/06. Open forum infectious diseases, 10 (6) pp. ofad247. Peer-reviewed.
 
Solid organ transplantation: Need of a new paradigm integrating biological sex.
Rello J., Manuel O., Pont T., 2023/06. European journal of internal medicine, 112 p. 117. Peer-reviewed.
Things We Do for No Reason™: Computed tomography of the head before lumbar puncture in low-risk adults and children.
Regina J., Manuel O., 2023/06. Journal of hospital medicine, 18 (6) pp. 534-537. Peer-reviewed.
 
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity.
Halfon M., Zhang L., Ehirchiou D., Pandian V.D., Dahdal S., Huynh-Do U., Pasch A., Ribi C., Busso N., 2023/05/18. Genes, 14 (5) p. 1105. Peer-reviewed.
 
Hilar arteriovenous fistula complicated by renal vein stenosis in kidney allograft.
Stavart L., Golshayan D., Qanadli S.D., Halfon M., 2023/05. Kidney international, 103 (5) pp. 999-1000. Peer-reviewed.
 
Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés [Update on the management of cytomegalovirus infection in transplant recipients]
Neofytos D., Van Delden C., Manuel O., 2023/04/12. Revue medicale suisse, 19 (822) pp. 726-730. Peer-reviewed.
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti L.N., Mugglin C., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N.J., Berger C., Boggian K., Garzoni C. et al., 2023/04/03. JAMA network open, 6 (4) pp. e2310687. Peer-reviewed.
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Griessbach A., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2023/04. Open forum infectious diseases, 10 (4) pp. ofad150. Peer-reviewed.
 
Preemptive therapy versus universal prophylaxis: Time for reconciliation?
Kampouri E., Manuel O., 2023/04. Transplant infectious disease, 25 (2) pp. e14014. Peer-reviewed.
 
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019.
Gutiérrez-Abejón E., Criado-Espegel P., Pedrosa-Naudín M.A., Fernández-Lázaro D., Herrera-Gómez F., Álvarez F.J., 2023/03/29. Pharmaceuticals, 16 (4) p. 508. Peer-reviewed.
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol.
Schwab S., Sidler D., Haidar F., Kuhn C., Schaub S., Koller M., Mellac K., Stürzinger U., Tischhauser B., Binet I. et al., 2023/03/07. Diagnostic and prognostic research, 7 (1) p. 6. Peer-reviewed.
Incidence, Risk Factors, and Management of Incisional Hernias After Kidney Transplant: A 20-Year Single Center Experience.
Costa L., Martin D., Zingg T., Venetz J.P., Demartines N., Golshayan D., Matter M., 2023/03. Transplantation proceedings, 55 (2) pp. 337-341. Peer-reviewed.
 
The effect of sex inequality on solid organ transplantation: A systematic review and meta-analysis.
Tejada S., Martinez-Reviejo R., Nogueira T.A., Gómez A., Pont T., Liao X., Zhang Z., Manuel O., Rello J., 2023/03. European journal of internal medicine, 109 pp. 58-67. Peer-reviewed.
 
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
Mejia-Chew C., Carver P.L., Rutjanawech S., Camargo LFA, Fernandes R., Belga S., Daniels S.A., Müller N.J., Burkhard S., Theodoropoulos N.M. et al., 2023/02/08. Clinical infectious diseases, 76 (3) pp. e995-e1003. Peer-reviewed.
 
Outcomes of SARS-CoV-2 infection among lung transplant recipients: A single center retrospective study.
Casutt A., Papadimitriou-Olivgeris M., Ioakeim F., Aubert J.D., Manuel O., Koutsokera A., 2023/02. Transplant infectious disease, 25 (1) pp. e14007. Peer-reviewed.
Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.
Coukos A., Vionnet J., Sempoux C., Fraga M., 2023/02. Journal for immunotherapy of cancer, 11 (2) pp. e006877. Peer-reviewed.
 
Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
Bestard O., Kaminski H., Couzi L., Fernández-Ruiz M., Manuel O., 2023. Transplant international, 36 p. 11963. Peer-reviewed.
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
de Rougemont O., Deng Y., Frischknecht L., Wehmeier C., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2023. Frontiers in immunology, 14 p. 1104371. Peer-reviewed.
Pregnancy after kidney transplantation: an observational study on maternal, graft and offspring outcomes in view of current literature.
Stavart L., Verly C., Venetz J.P., Baud D., Legardeur H., Vial Y., Golshayan D., 2023. Frontiers in nephrology, 3 p. 1216762. Peer-reviewed.
Échinococcose alvéolaire chez les receveurs d'une greffe d'organe solide : une série de cas de deux cohortes nationales [Alveolar echinococcosis in solid organ transplant recipients: a case series from two national cohorts]
Marquis B., Demonmerot F., Richou C., Thiéfin G., Millon L., Wallon M., Vuitton D.A., Grall-Jezequel A., Grenouillet F., Epaulard O. et al., 2023. Parasite, 30 p. 9. Peer-reviewed.
 
Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
Schaller J., Hajjami H.M., Rusakiewicz S., Ioannidou K., Piazzon N., Miles A., Golshayan D., Gaide O., Hohl D., Speiser D.E. et al., 2022/12/06..
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study.
Pedrosa-Naudín M.A., Gutiérrez-Abejón E., Herrera-Gómez F., Fernández-Lázaro D., Álvarez F.J., 2022/12/02. Pharmaceutics, 14 (12) p. 2696. Peer-reviewed.
Differences Between Centers in Psychosocial Evaluations for Living Kidney Donors Do Not Influence Outcome: Results From an Observational Multicenter Study.
Ludwig G., Geiger I., Götzmann L., Jordan K.D., Döbbel S., Klaghofer R., Salathé M., Stillhard U., Meinlschmidt G., Kiss A. et al., 2022/12. Transplantation direct, 8 (12) pp. e1400. Peer-reviewed.
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients.
Pham T.T., Andrey D.O., Stampf S., Burkhard S.H., Hirzel C., Tschopp J., Ullrich K., Strahm C., Schreiber P.W., Boillat-Blanco N. et al., 2022/12. American journal of transplantation, 22 (12) pp. 3031-3046. Peer-reviewed.
 
Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study.
Rivière A., Picard C., Berastegui C., Mora V.M., Bunel V., Godinas L., Salvaterra E., Rossetti V., Savale L., Israel-Biet D. et al., 2022/12. American journal of transplantation, 22 (12) pp. 2990-3001. Peer-reviewed.
 
Regression of Graft Steatosis After Liver Transplantation.
Meyer H., Maurer M.H., Staufer K., Berzigotti A., Banz V., Swiss Transplant Cohort Study, 2022/12. Progress in transplantation, 32 (4) pp. 321-326. Peer-reviewed.
Robotic versus hand-assisted laparoscopic living donor nephrectomy: comparison of two minimally invasive techniques in kidney transplantation.
Windisch O.L., Matter M., Pascual M., Sun P., Benamran D., Bühler L., Iselin C.E., 2022/12. Journal of robotic surgery, 16 (6) pp. 1471-1481. Peer-reviewed.
Antimicrobial stewardship programs in solid-organ transplant recipients in Switzerland.
Bielicki J.A., Manuel O., Swiss Transplant Cohort Study (STCS), 2022/10. Transplant infectious disease, 24 (5) pp. e13902. Peer-reviewed.
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Laager M., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2022/10. The Journal of hospital infection, 128 pp. 47-53. Peer-reviewed.
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study.
Becchetti C., Dirchwolf M., Schropp J., Magini G., Müllhaupt B., Immer F., Dufour J.F., Banz V., Berzigotti A., Bosch J. et al., 2022/10. Alimentary pharmacology & therapeutics, 56 (7) pp. 1194-1204. Peer-reviewed.
 
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Hirzel C., Projer L., Atkinson A., Surial B., Mueller N.J., Manuel O., Mombelli M., van Delden C., Hirsch H.H., Boggian K. et al., 2022/09/01. Transplantation, 106 (9) pp. 1875-1883. Peer-reviewed.
 
Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.
Tejada S., Martinez-Reviejo R., Karakoc H.N., Peña-López Y., Manuel O., Rello J., 2022/09. Advances in therapy, 39 (9) pp. 4037-4051. Peer-reviewed.
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
Speich B., Chammartin F., Abela I.A., Amico P., Stoeckle M.P., Eichenberger A.L., Hasse B., Braun D.L., Schuurmans M.M., Müller T.F. et al., 2022/08/24. Clinical infectious diseases, 75 (1) pp. e585-e593. Peer-reviewed.
 
Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
Girardin F., Manuel O., Marzolini C., Buclin T., 2022/08. Clinical microbiology and infection, 28 (8) pp. 1044-1046. Peer-reviewed.
Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review.
Martinez-Reviejo R., Tejada S., Cipriano A., Karakoc H.N., Manuel O., Rello J., 2022/08. Anaesthesia, critical care & pain medicine, 41 (4) p. 101098. Peer-reviewed.
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients.
Dos Santos Q., Wareham N.E., Mocroft A., Rasmussen A., Gustafsson F., Perch M., Sørensen S.S., Manuel O., Müller N.J., Lundgren J. et al., 2022/07/04. Cancers, 14 (13) p. 3279. Peer-reviewed.
Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes.
Brune J.E., Dickenmann M., Wehmeier C., Sidler D., Walti L., Golshayan D., Manuel O., Hadaya K., Neofytos D., Schnyder A. et al., 2022/07. American journal of transplantation, 22 (7) pp. 1823-1833. Peer-reviewed.
Predictive Factors of Surgical Complications in the First Year Following Kidney Transplantation.
Salamin P., Deslarzes-Dubuis C., Longchamp A., Petitprez S., Venetz J.P., Corpataux J.M., Déglise S., 2022/07. Annals of vascular surgery, 83 pp. 142-151. Peer-reviewed.
 
The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality.
Dirchwolf M., Becchetti C., Gschwend S.G., Toso C., Dutkowski P., Immer F., Beyeler F., Rossi S., Schropp J., Dufour J.F. et al., 2022/07. HPB, 24 (7) pp. 1168-1176. Peer-reviewed.
Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival.
Gutiérrez-Abejón E., Herrera-Gómez F., Pedrosa-Naudín M.A., Tamayo E., Álvarez F.J., 2022/06/19. Medicina, 58 (6) p. 829. Peer-reviewed.
The Rational Use of Complement Inhibitors in Kidney Diseases.
Fakhouri F., Schwotzer N., Golshayan D., Frémeaux-Bacchi V., 2022/06. Kidney international reports, 7 (6) pp. 1165-1178. Peer-reviewed.
Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study.
Jäger C., Stampf S., Molyneux K., Barratt J., Golshayan D., Hadaya K., Huynh-Do U., Binet F.I., Mueller T.F., Koller M. et al., 2022/05/10. BMC nephrology, 23 (1) p. 178. Peer-reviewed.
Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach.
van den Bogaart L., Manuel O., 2022/05/02. Antibiotics, 11 (5) p. 612. Peer-reviewed.
 
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review.
Filippidis P., Vionnet J., Manuel O., Mombelli M., 2022/05. Expert review of anti-infective therapy, 20 (5) pp. 663-680. Peer-reviewed.
 
Humoral response to SARS-CoV-2 infection among liver transplant recipients.
Becchetti C., Broekhoven AGC, Dahlqvist G., Fraga M., Zambelli M.F., Ciccarelli O., Saouli A.C., Trizzino A., Banz V., Dufour J.F. et al., 2022/04. Gut, 71 (4) pp. 746-756. Peer-reviewed.
Letter Regarding "Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis".
Halfon M., Schwotzer N., Pruijm M., Bonny O., 2022/04. Kidney international reports, 7 (4) pp. 930-931. Peer-reviewed.
 
Relevance of deceased donor proteinuria for kidney transplantation: A comprehensive national cohort study.
Kuhn C., Born A., Karolin A., Lang B., Binet I., Golshayan D., Haidar F., Müller T.F., Schaub S., Immer F. et al., 2022/04. Clinical transplantation, 36 (4) pp. e14574. Peer-reviewed.
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
Albasanz-Puig A., Durà-Miralles X., Laporte-Amargós J., Mussetti A., Ruiz-Camps I., Puerta-Alcalde P., Abdala E., Oltolini C., Akova M., Montejo J.M. et al., 2022/03/29. Microorganisms, 10 (4) p. 733. Peer-reviewed.
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.
Kasmi S., Artru F., Barbosa J.V., Deibel A.R., Favre L., Peuble C., Saouli A.C., Goossens N., Müllhaupt B., Pascual M. et al., 2022/02/28. Swiss medical weekly, 152 pp. w30138. Peer-reviewed.
Has the profile of heart transplantation recipients changed within the last three decades?
Anouck Z., Tozzi P., Regamey J., Abdurashidova T., Meyer P., Lefol K., Pascual M., Yerly P., Aubert V., Aur S. et al., 2022/01/17. Swiss medical weekly, 152 pp. w30108. Peer-reviewed.
 
Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality.
Martín-Fernández M., Heredia-Rodríguez M., González-Jiménez I., Lorenzo-López M., Gómez-Pesquera E., Poves-Álvarez R., Álvarez F.J., Jorge-Monjas P., Beltrán-DeHeredia J., Gutiérrez-Abejón E. et al., 2022/01/10. Critical care, 26 (1) p. 4. Peer-reviewed.
A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study.
Beckmann S., Mauthner O., Schick L., Rochat J., Lovis C., Boehler A., Binet I., Huynh-Do U., De Geest S., Psychosocial Interest Group et al., 2022. Transplant international, 35 p. 10255. Peer-reviewed.
Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation.
Porret R., Meier RPH, Mikulic J., Pascual M., Aubert V., Harr T., Golshayan D., Muller Y.D., 2022. Frontiers in immunology, 13 p. 997364. Peer-reviewed.
 
Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?
Vionnet J., Sánchez-Fueyo A., 2022/01. Liver transplantation, 28 (1) pp. 15-16. Peer-reviewed.
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.
Yerly P., Rotman S., Regamey J., Aubert V., Aur S., Kirsch M., Hullin R., Pascual M., 2022/01. Xenotransplantation, 29 (1) pp. e12726. Peer-reviewed.
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
van den Bogaart L., Lang B.M., Neofytos D., Egli A., Walti L.N., Boggian K., Garzoni C., Berger C., Pascual M., van Delden C. et al., 2022/01. American journal of transplantation, 22 (1) pp. 199-209. Peer-reviewed.
Kidney Transplantation in Patients With Active SARS-CoV-2 Replication: An Initial Case Series.
Halfon M., Stavart L., Venetz J.P., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10716. Peer-reviewed.
 
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Papadimitriou-Olivgeris M., Cipriano A., Guggisberg N., Kroemer M., Tschopp J., Manuel O., Golshayan D., 2022. Transplant international, 35 p. 10721. Peer-reviewed.
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation - Data from the Swiss transplant cohort study.
Frischknecht L., Deng Y., Wehmeier C., de Rougemont O., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2022. Frontiers in immunology, 13 p. 1005790. Peer-reviewed.
 
Xenotransplantation: A New Era.
Carrier A.N., Verma A., Mohiuddin M., Pascual M., Muller Y.D., Longchamp A., Bhati C., Buhler L.H., Maluf D.G., Meier RPH, 2022. Frontiers in immunology, 13 p. 900594. Peer-reviewed.
Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland.
Stampf S., Mueller N.J., van Delden C., Pascual M., Manuel O., Banz V., Binet I., De Geest S., Bochud P.Y., Leichtle A. et al., 2021/12/15. BMJ open, 11 (12) pp. e051176. Peer-reviewed.
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
Burwick R.M., Yawetz S., Stephenson K.E., Collier A.Y., Sen P., Blackburn B.G., Kojic E.M., Hirshberg A., Suarez J.F., Sobieszczyk M.E. et al., 2021/12/06. Clinical infectious diseases, 73 (11) pp. e3996-e4004. Peer-reviewed.
 
Non-invasive alloimmune risk stratification of long-term liver transplant recipients.
Vionnet J., Miquel R., Abraldes J.G., Wall J., Kodela E., Lozano J.J., Ruiz P., Navasa M., Marshall A., Nevens F. et al., 2021/12. Journal of hepatology, 75 (6) pp. 1409-1419. Peer-reviewed.
 
Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study.
Wehmeier C., Amico P., Sidler D., Wirthmüller U., Hadaya K., Ferrari-Lacraz S., Golshayan D., Aubert V., Schnyder A., Sunic K. et al., 2021/12. Transplant international, 34 (12) pp. 2755-2768. Peer-reviewed.
Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?
Tau N., Manuel O., Rozen-Zvi B., Shargian L., Yahav D., 2021/12. Clinical microbiology and infection, 27 (12) pp. 1727-1728. Peer-reviewed.
 
A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death.
Gutiérrez-Abejón E., Herrera-Gómez F., Martín-García D., Tamayo E., Álvarez F.J., 2021/11/29. Journal of cardiovascular development and disease, 8 (12) p. 167. Peer-reviewed.
 
COVID-19 as a potential trigger of complement-mediated atypical HUS.
El Sissy C., Saldman A., Zanetta G., Martins P.V., Poulain C., Cauchois R., Kaplanski G., Venetz J.P., Bobot M., Dobosziewicz H. et al., 2021/11/04. Blood, 138 (18) pp. 1777-1782. Peer-reviewed.
Viral infections in lung transplantation.
Munting A., Manuel O., 2021/11. Journal of thoracic disease, 13 (11) pp. 6673-6694. Peer-reviewed.
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
Speich B., Chammartin F., Smith D., Stoeckle M.P., Amico P., Eichenberger A.L., Hasse B., Schuurmans M.M., Müller T., Tamm M. et al., 2021/10/21. Trials, 22 (1) p. 724. Peer-reviewed.
 
Regulation of Fibroblast Activation Protein-α Expression: Focus on Intracellular Protein Interactions.
Juillerat-Jeanneret L., Tafelmeyer P., Golshayan D., 2021/10/14. Journal of medicinal chemistry, 64 (19) pp. 14028-14045. Peer-reviewed.
 
Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: A scoping review.
Appenzeller-Herzog C., Hartleif S., Vionnet J., 2021/10. American journal of transplantation, 21 (10) pp. 3312-3323. Peer-reviewed.
SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
Giannella M., Pierrotti L.C., Helanterä I., Manuel O., 2021/10. Transplant international, 34 (10) pp. 1776-1788. Peer-reviewed.
 
Use of induction therapy in pediatric heart transplant recipients in Switzerland - Analysis of the Swiss national database.
Schweiger M., Erdil T., Di Bernardo S., Balmer C., Yildiz M., Kadner A., Swiss Transplant Cohort Study, 2021/10. Transplant immunology, 68 p. 101443. Peer-reviewed.
Tribute to Professor Stefan Kunz.
Pascual M., 2021/09/18. Viruses, 13 (9) p. 1862. Peer-reviewed.
Hypertension après transplantation rénale [Hypertension after kidney transplantation]
Schwotzer N., Wuerzner G., Golshayan D., 2021/09/15. Revue medicale suisse, 17 (750) pp. 1571-1574. Peer-reviewed.
Hépatite autoimmune : mise au point 2021 [Autoimmune hepatitis: 2021 update]
Stamm G.M., Sempoux C., Fraga M., Comte D., Aubert V., Moradpour D., Vionnet J., Moschouri E., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1457-1463. Peer-reviewed.
 
Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial.
Mombelli M., Hoschler K., Cavassini M., Pascual M., Manuel O., 2021/09. The Journal of infection, 83 (3) pp. 354-360. Peer-reviewed.
Impact of Hyponatremia after Renal Transplantation on Decline of Renal Function, Graft Loss and Patient Survival: A Prospective Cohort Study.
Berchtold L., Filzer A., Achermann R., Devetzis V., Dahdal S., Bonani M., Schnyder A., Golshayan D., Amico P., Huynh-Do U. et al., 2021/08/27. Nutrients, 13 (9) p. 2995. Peer-reviewed.
 
Pneumocystis jirovecii Pneumonia and Use of mTOR Inhibitors in Kidney Transplantation.
Coussement J., Manuel O., 2021/08/16. Clinical infectious diseases, 73 (4) pp. 752-753. Peer-reviewed.
Demographic, psychosocial and health disparities between living and deceased renal allograft recipients in Switzerland.
Achermann R., Koller M., De Geest S., Hadaya K., Müller T.F., Huynh-Do U., Pascual M., Steiger J., Kiss A., Binet I. et al., 2021/08/02. Swiss medical weekly, 151 pp. w20532. Peer-reviewed.
COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary.
Manuel O., 2021/08. Clinical microbiology and infection, 27 (8) pp. 1070-1071. Peer-reviewed.
 
The future of SARS-CoV-2 vaccines in transplant recipients: To be determined.
Blumberg E.A., Manuel O., Sester M., Ison M.G., 2021/08. American journal of transplantation, 21 (8) pp. 2629-2630. Peer-reviewed.
 
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity.
Manuel O., Avery R.K., 2021/08/01. Current opinion in infectious diseases, 34 (4) pp. 307-313. Peer-reviewed.
Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports.
Chehade H., Guzzo G., Cachat F., Rotman S., Teta D., Pantaleo G., Sadallah S., Sharma A., Rosales I.A., Tolkoff-Rubin N. et al., 2021/07/31. Frontiers in medicine, 8 p. 663258. Peer-reviewed.
Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G., Kissling S., Pantaleo G., Pascual M., Sadallah S., Teta D., 2021/07/06. BMC nephrology, 22 (1) p. 252. Peer-reviewed.
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Bressin P., Senn L., Grandbastien B., Andre C. et al., 2021/07/05. BMJ open, 11 (7) pp. e049232. Peer-reviewed.
 
Acute renal dysfunction after simultaneous pancreas-kidney transplantation.
Gialamas E., Assalino M., Golshayan D., Berney T., 2021/07. American journal of transplantation, 21 (7) pp. 2610-2613. Peer-reviewed.
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
Walti L.N., Mugglin C., Sidler D., Mombelli M., Manuel O., Hirsch H.H., Khanna N., Mueller N., Berger C., Boggian K. et al., 2021/07. American journal of transplantation, 21 (7) pp. 2532-2542. Peer-reviewed.
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study.
Mombelli M., Lang B.M., Neofytos D., Aubert J.D., Benden C., Berger C., Boggian K., Egli A., Soccal P.M., Kaiser L. et al., 2021/05. American journal of transplantation, 21 (5) pp. 1789-1800. Peer-reviewed.
 
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A., Mohiuddin M., Manuel O., Vrakas G., Maluf D.G., Buhler L.H., Muller Y.D., Pascual M., 2021/05. Xenotransplantation, 28 (3) pp. e12681. Peer-reviewed.
 
Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease.
Herrera-Gómez F., Álvarez F.J., 2021/04/29. Biomedicines, 9 (5) p. 488. Peer-reviewed.
 
Bronchial anastomosis dehiscence and stenosis caused by donor-transmitted Mycoplasma hominis infection in a lung transplant recipient: Case report and literature review.
Vecchio M., Koutsokera A., Touilloux B., Perentes J.Y., Manuel O., Noirez L., Aubert J.D., Lenoir A., 2021/04. Transplant infectious disease, 23 (2) pp. e13475. Peer-reviewed.
 
Outcome of kidney transplantation from very senior donors in Switzerland - a national cohort study.
Kuhn C., Lang B.M., Lörcher S., Karolin A., Binet I., Beldi G., Golshayan D., Hadaya K., Mueller T.F., Schaub S. et al., 2021/04. Transplant international, 34 (4) pp. 689-699. Peer-reviewed.
 
Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation: The Swiss Transplant Cohort study.
Denhaerynck K., Goldfarb-Rumyantzev A.S., Sandhu G., Beckmann S., Huynh-Do U., Binet I., De Geest S., Psychosocial Interest Group, Swiss Transplant Cohort Study, 2021/04. Clinical transplantation, 35 (4) pp. e14218. Peer-reviewed.
 
Rhizomucor hepatosplenic abscesses in a patient with renal and pancreatic transplantation.
Schneider M., Kobayashi K., Uldry E., Demartines N., Golshayan D., Halkic N., 2021/04. Annals of the Royal College of Surgeons of England, 103 (4) pp. e131-e135. Peer-reviewed.
Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
Schaller J., Hajjami H.M., Rusakiewicz S., Ioannidou K., Piazzon N., Miles A., Golshayan D., Gaide O., Hohl D., Speiser D.E. et al., 2021/03/30. Oncotarget, 12 (7) pp. 638-648. Peer-reviewed.
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
Kohler P., Wolfensberger A., Stampf S., Brönnimann A., Boggian K., van Delden C., Favre M., Hirzel C., Khanna N., Kuster S.P. et al., 2021/03/07. Antimicrobial resistance and infection control, 10 (1) p. 50. Peer-reviewed.
Impact of COVID-19 in solid organ transplant recipients.
Danziger-Isakov L., Blumberg E.A., Manuel O., Sester M., 2021/03. American journal of transplantation, 21 (3) pp. 925-937. Peer-reviewed.
Pulmonary angioplasty: A step further in the continuously changing landscape of chronic thromboembolic pulmonary hypertension management.
Rotzinger D.C., Rezaei-Kalantari K., Aubert J.D., Qanadli S.D., 2021/03. European journal of radiology, 136 p. 109562. Peer-reviewed.
Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes.
Schwotzer N., Provot F., Ville S., Daniel L., Le Fur A., Kissling S., Jourde-Chiche N., Karras A., Moreau A., Augusto J.F. et al., 2021/03. Kidney international reports, 6 (3) pp. 746-754. Peer-reviewed.
 
Understanding rare infections post-lung transplantation.
van den Bogaart L., Cipriano A., Koutsokera A., Manuel O., 2021/03. Expert review of respiratory medicine, 15 (3) pp. 325-338. Peer-reviewed.
Complément et rein [Complement system and kidney]
Halfon M., Pascual M., Sadallah S., Fakhouri F., 2021/02/24. Revue medicale suisse, 17 (727) pp. 383-388. Peer-reviewed.
Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study.
Beerli N., Denhaerynck K., Binet I., Dahdal S., Dickenmann M., Golshayan D., Hadaya K., Huynh-Do U., Schnyder A., De Geest S.M. et al., 2021. Transplant international, 35 p. 10076. Peer-reviewed.
Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials.
Lizaraso-Soto F., Gutiérrez-Abejón E., Bustamante-Munguira J., Martín-García D., Chimeno M.M., Nava-Rebollo Á., Maurtua-Briseño-Meiggs Á., Fernández-Zoppino D., Bustamante-Munguira E., de Paz F.J. et al., 2021. Frontiers in medicine, 8 p. 686729. Peer-reviewed.
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
Guzzo G., Sadallah S., Fodstad H., Venetz J.P., Rotman S., Teta D., Gauthier T., Pantaleo G., Superti-Furga A., Pascual M., 2021. Frontiers in genetics, 12 p. 529236. Peer-reviewed.
 
Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis.
Gutiérrez-Abejón E., Martín-García D., Tamayo E., Álvarez F.J., Herrera-Gómez F., 2021. Frontiers in medicine, 8 p. 657977. Peer-reviewed.
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet N., Fernández-Ruiz M., Binet I., Dickenmann M., Dahdal S., Hadaya K., Müller T., Schaub S., Koller M., Rotman S. et al., 2021. PloS one, 16 (4) pp. e0250829. Peer-reviewed.
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
Bibert S., Guex N., Lourenco J., Brahier T., Papadimitriou-Olivgeris M., Damonti L., Manuel O., Liechti R., Götz L., Tschopp J. et al., 2021. Frontiers in immunology, 12 p. 666163. Peer-reviewed.
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.
Benden C., Haile S., Kruegel N., Beyeler F., Aubert J.D., Binet I., Golshayan D., Hadaya K., Mueller T., Parvex P. et al., 2020/12/14. Swiss medical weekly, 150 pp. w20451. Peer-reviewed.
 
Dialysis after graft loss: a Swiss experience.
Bonani M., Achermann R., Seeger H., Scharfe M., Müller T., Schaub S., Binet I., Huynh-Do U., Dahdal S., Golshayan D. et al., 2020/12/04. Nephrology, dialysis, transplantation, 35 (12) pp. 2182-2190. Peer-reviewed.
 
Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients.
Coussement J., Kaminski H., Scemla A., Manuel O., 2020/12. Current opinion in infectious diseases, 33 (6) pp. 419-425. Peer-reviewed.
 
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020.
Lortholary O., Fernandez-Ruiz M., Baddley J.W., Manuel O., Mariette X., Winthrop K.L., 2020/12. Annals of the rheumatic diseases, 79 (12) pp. 1532-1543. Peer-reviewed.
 
Understanding, predicting and achieving liver transplant tolerance: from bench to bedside.
Thomson A.W., Vionnet J., Sanchez-Fueyo A., 2020/12. Nature reviews. Gastroenterology & hepatology, 17 (12) pp. 719-739. Peer-reviewed.
Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
Krisl A., Stampf S., Hauri D., Binet I., Mueller T., Sidler D., Hadaya K., Golshayan D., Pascual M., Koller M. et al., 2020/11/30. Swiss medical weekly, 150 pp. w20354. Peer-reviewed.
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation.
Martinu T., Koutsokera A., Benden C., Cantu E., Chambers D., Cypel M., Edelman J., Emtiazjoo A., Fisher A.J., Greenland J.R. et al., 2020/11. The Journal of heart and lung transplantation, 39 (11) pp. 1171-1190. Peer-reviewed.
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study.
van Delden C., Stampf S., Hirsch H.H., Manuel O., Meylan P., Cusini A., Hirzel C., Khanna N., Weisser M., Garzoni C. et al., 2020/10/23. Clinical infectious diseases, 71 (7) pp. e159-e169. Peer-reviewed.
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Tschopp J., L'Huillier A.G., Mombelli M., Mueller N.J., Khanna N., Garzoni C., Meloni D., Papadimitriou-Olivgeris M., Neofytos D., Hirsch H.H. et al., 2020/10. American journal of transplantation, 20 (10) pp. 2876-2882. Peer-reviewed.
The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies.
Bernuy-Guevara C., Chehade H., Muller Y.D., Vionnet J., Cachat F., Guzzo G., Ochoa-Sangrador C., Álvarez F.J., Teta D., Martín-García D. et al., 2020/09/16. Biomedicines, 8 (9) pp. E355. Peer-reviewed.
 
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study.
Vu D.L., Dayer J.A., Masouridi-Levrat S., Combescure C., Boely E., Khanna N., Mueller N.J., Kleber M., Medinger M., Halter J. et al., 2020/08. Transplant infectious disease, 22 (4) pp. e13289. Peer-reviewed.
 
COVID-19: A global transplant perspective on successfully navigating a pandemic.
Kumar D., Manuel O., Natori Y., Egawa H., Grossi P., Han S.H., Fernández-Ruiz M., Humar A., 2020/07. American journal of transplantation, 20 (7) pp. 1773-1779. Peer-reviewed.
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Schwotzer N., Paganetti G., Barchi M., Perrottet N., Aubert V., Sadallah S., Rotman S., Venetz J.P., Matter M., Golshayan D. et al., 2020/07. Xenotransplantation, 27 (4) pp. e12630. Peer-reviewed.
Diabète post-transplantation rénale: le point de vue du diabétologue [Post-transplantation diabetes in kidney transplant: from the diabetologist point of view]
Pauchet A., Schwotzer N., Lamine F., Perrottet N., Zanchi A., Golshayan D., Wojtusciszyn A., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1200-1205. Peer-reviewed.
Combined Lung and Liver Transplantation for Short Telomere Syndrome.
Moschouri E., Vionnet J., Giostra E., Daccord C., Lazor R., Sciarra A., Letovanec I., Sempoux C., Gonzalez M., Unger S. et al., 2020/06. Liver transplantation, 26 (6) pp. 840-844. Peer-reviewed.
Impact of kidney transplantation on sleep apnea severity: A prospective polysomnographic study.
Forni Ogna V., Ogna A., Haba-Rubio J., Nowak G., Venetz J.P., Golshayan D., Matter M., Burnier M., Pascual M., Heinzer R., 2020/06. American journal of transplantation, 20 (6) pp. 1659-1667. Peer-reviewed.
SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm]
Tadini E., Papamidimitriou-Olivgeris M., Opota O., Moulin E., Lamoth F., Manuel O., Lhopitallier L., Jaton K., Croxatto A., Grandbastien B. et al., 2020/05/06. Revue medicale suisse, 16 (692) pp. 917-923. Peer-reviewed.
Real-life food-safety behavior and incidence of foodborne infections in solid organ transplant recipients.
Lindup M., van den Bogaart L., Golshayan D., Aubert J.D., Vionnet J., Regamey J., Pascual M., Manuel O., Mombelli M., 2020/05. American journal of transplantation, 20 (5) pp. 1424-1430. Peer-reviewed.
Infection à SARS-CoV-2 et transplantation d’organes solides [SARS-CoV-2 infection and solid organ transplantation]
Golshayan D., Aubert J.D., Hullin R., Moradpour D., Venetz J.P., Manuel O., Pascual M., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 815-818. Peer-reviewed.
Risques infectieux des nouveaux biologiques immunosuppresseurs : quelles prophylaxies et quand ? [Infectious risks of new immunosuppressive biologicals : which prophylaxis and when ?]
Rochat Stettler L., Nguyen A., Manuel O., Van Delden C., 2020/04/15. Revue medicale suisse, 16 (690) pp. 724-730. Peer-reviewed.
 
The Other Angiotensin II Receptor: AT2R as a Therapeutic Target
Juillerat-Jeanneret L., 2020/03/12. Journal of medicinal chemistry, 63 (5) pp. 1978-1995. Peer-reviewed.
Management of allergy transfer upon solid organ transplantation.
Muller Y.D., Vionnet J., Beyeler F., Eigenmann P., Caubet J.C., Villard J., Berney T., Scherer K., Spertini F., Fricker M.P. et al., 2020/03. American journal of transplantation, 20 (3) pp. 834-843. Peer-reviewed.
 
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.
Mombelli M., Kampouri E., Manuel O., 2020/02. Expert review of anti-infective therapy, 18 (2) pp. 103-112. Peer-reviewed.
 
Vitamin D deficiency is common in kidney transplant recipients, but is not associated with infections after transplantation.
Schreiber P.W., Kusejko K., Bischoff-Ferrari H.A., Boggian K., Bonani M., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H. et al., 2020/02. Clinical transplantation, 34 (2) pp. e13778. Peer-reviewed.
Donor-specific antibodies in liver transplantation.
Vionnet J., Sempoux C., Pascual M., Sánchez-Fueyo A., Colmenero J., 2020/01. Gastroenterologia y hepatologia, 43 (1) pp. 34-45. Peer-reviewed.
 
Immune-Mediated Liver Disease in the Transplanted Liver
Vionnet Julien, Sanchez-Fueyo Alberto, Neuberger James, 2020. pp. 597-620 dans Liver Immunology chap. 36, Springer International Publishing.
Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L., Mikulic J., Wyss J.C., Gaide O., Thome M., Golshayan D., 2020. Frontiers in immunology, 11 p. 576651. Peer-reviewed.
Impact of an intra-abdominal cooling device during open kidney transplantation in pigs.
Longchamp A., Meier RPH, Colucci N., Balaphas A., Orci L.A., Nastasi A., Longchamp G., Moll S., Klauser A., Pascual M. et al., 2019/12/16. Swiss medical weekly, 149 pp. w20143. Peer-reviewed.
 
Blood CD9<sup>+</sup> B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation.
Brosseau C., Danger R., Durand M., Durand E., Foureau A., Lacoste P., Tissot A., Roux A., Reynaud-Gaubert M., Kessler R. et al., 2019/11. American journal of transplantation, 19 (11) pp. 3162-3175. Peer-reviewed.
Nonvascularized human skin chronic allograft rejection.
Rotman S., Koch N., Wiesner L., Aubert V., Rosales I.A., Colvin R.B., Raffoul W., Pascual M., 2019/11. American journal of transplantation, 19 (11) pp. 3191-3196. Peer-reviewed.
 
Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey.
Shepshelovich D., Tau N., Green H., Rozen-Zvi B., Issaschar A., Falcone M., Coussement J., Zusman O., Manuel O., Mor E. et al., 2019/10. Transplant infectious disease, 21 (5) pp. e13134. Peer-reviewed.
 
Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology.
Rammaert B., Puyade M., Cornely O.A., Seidel D., Grossi P., Husain S., Picard C., Lass-Flörl C., Manuel O., Le Pavec J. et al., 2019/10. Transplant infectious disease, 21 (5) pp. e13141. Peer-reviewed.
 
Burden of end-stage renal disease and evolving challenges in kidney transplantation.
Golshayan D., Pascual M., 2019/09. Transplant international, 32 (9) pp. 889-891. Peer-reviewed.
 
Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study.
Law N., Hamandi B., Fegbeutel C., Silveira F.P., Verschuuren E.A., Ussetti P., Chin-Hong P.V., Sole A., Holmes-Liew C.L., Billaud E.M. et al., 2019/09. The Journal of heart and lung transplantation, 38 (9) pp. 963-971. Peer-reviewed.
 
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
Duss F.R., Garcia de la Mària C., Croxatto A., Giulieri S., Lamoth F., Manuel O., Miró J.M., 2019/09/01. The Journal of antimicrobial chemotherapy, 74 (9) pp. 2626-2630. Peer-reviewed.
 
Suivi ambulatoire du patient transplanté hépatique: le rôle essentiel du médecin généraliste [Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]
Henchoz S., Fraga M., Saouli A.C., Elkrief L., Berney T., Toso C., Compagnon P., Andres A., Denys A., Pascual M. et al., 2019/08/28. Revue medicale suisse, 15 (660) pp. 1488-1495. Peer-reviewed.
Syndrome d’Alagille [Alagille Syndrome]
Wakim El-Khoury J., Venetz J.P., Rutz T., Sciarra A., Unger S., Sempoux C., Moradpour D., Fraga M., 2019/08/28. Revue medicale suisse, 15 (660) pp. 1506-1510. Peer-reviewed.
 
Rethinking bronchoalveolar lavage in acute cellular rejection: How golden is the standard of transbronchial biopsies?
Koutsokera A., 2019/08. The Journal of heart and lung transplantation, 38 (8) pp. 856-857. Peer-reviewed.
 
Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Kaminski H., Jarque M., Halfon M., Taton B., Di Ascia L., Pfirmann P., Visentin J., Garrigue I., Déchanet-Merville J., Moreau J.F. et al., 2019/07/31. The Journal of infectious diseases, 220 (5) pp. 761-771. Peer-reviewed.
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
Fraga M., Gouttenoire J., Sahli R., Chtioui H., Marcu C., Pascual M., Moradpour D., Vionnet J., 2019/05/24. BMC gastroenterology, 19 (1) p. 76. Peer-reviewed.
 
Clinical relevance of preservation-fluid contamination in solid-organ transplantation: a call for mounting the evidence.
Yahav D., Manuel O., 2019/05. Clinical microbiology and infection, 25 (5) pp. 536-537. Peer-reviewed.
 
Evaluation of donor kidneys prior to transplantation: an update of current and emerging methods.
Moeckli B., Sun P., Lazeyras F., Morel P., Moll S., Pascual M., Bühler L.H., 2019/05. Transplant international, 32 (5) pp. 459-469. Peer-reviewed.
Swiss Recommendations for Adult Cystic Fibrosis Care: Transplantation
Benden Christian, McLin Valérie, Bürgi Urs, Huber Lars C., Koutsokera Angela, Aubert John-David, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
Swiss Recommendations for Adult Cystic Fibrosis Care: Burkholderia cepacia complex
Sauty Alain, Manuel Oriol, Koutsokera Angela, Tullis Elizabeth, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
Swiss Recommendations for Adult Cystic Fibrosis Care: Other relevant bacteria (Bordetella species)
Koutsokera Angela, Manuel Oriol, Sauty Alain, Müller Nicolas, Benden Christian, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
Swiss Recommendations for Adult Cystic Fibrosis Care: Staphylococcus aureus
Sauty Alain, Manuel Oriol, Koutsokera Angela, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
Swiss Recommendations for Adult Cystic Fibrosis Care: Vaccination
Manuel Oriol, Koutsokera Angela, Sauty Alain, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
Impact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: A systematic review and meta-analysis.
Fernández-Ruiz M., Giménez E., Lora D., Aguado J.M., Pascual M., Manuel O., 2019/04. American journal of transplantation, 19 (4) pp. 1072-1085. Peer-reviewed.
 
Compromised immunity and the microbiome: transplantation, cancer and HIV
Bernasconi Eric, Aubert John-David, Koutsokera Angela, Nicod Laurent P., Twigg III Homer L., 2019/03. pp. 195-215 dans The Lung Microbiome chap. 12, European Respiratory Society.
 
Variations et anomalies néphrologiques, vasculaires et urologiques chez les candidats au don vivant rénal [Renal, vascular and urological variations and abnormalities in living kidney donor candidates]
Costa A., Matter M., Pascual M., Doerfler A., Venetz J.P., 2019/03. Progres en urologie, 29 (3) pp. 166-172. Peer-reviewed.
 
Genetic and clinic predictors of new onset diabetes mellitus after transplantation.
Saigi-Morgui N., Quteineh L., Bochud P.Y., Crettol S., Kutalik Z., Mueller N.J., Binet I., Van Delden C., Steiger J., Mohacsi P. et al., 2019/02. The pharmacogenomics journal, 19 (1) pp. 53-64. Peer-reviewed.
Clinical parameters and biomarkers predicting spontaneous operational tolerance after liver transplantation: a scoping review protocol.
Appenzeller-Herzog C., Hartleif S., Vionnet J., 2019. F1000Research, 8 p. 2059. Peer-reviewed.
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH<sub>2</sub>) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury.
Wyss J.C., Kumar R., Mikulic J., Schneider M., Mary J.L., Aebi J.D., Juillerat-Jeanneret L., Golshayan D., 2019. Frontiers in pharmacology, 10 p. 1209. Peer-reviewed.
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
 
Hépatites / Hépatites virales / Vaccination: Hépatite A, B et A+B
Vionnet Julien, Fraga Montserrat, 2019/01/01. pp. 480-496 dans SURF: Guidelines Médecine interne générale, Editions D&F Gmbh/Sàrl.
 
Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Bischoff-Ferrari H.A., Boggian K., van Delden C., Enriquez N., Fehr T., Garzoni C., Hirsch H.H., Hirzel C., Manuel O. et al., 2019/01. Transplant international, 32 (1) pp. 49-58. Peer-reviewed.
Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. Data in brief, 21 pp. 2567-2575. Peer-reviewed.
 
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S., Stampf S., Gerber B., Baettig V., Weisser M., Gerull S., Medinger M., Passweg J., Schanz U., Garzoni C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12981. Peer-reviewed.
Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D., Hirzel C., Boely E., Lecompte T., Khanna N., Mueller N.J., Boggian K., Cusini A., Manuel O., van Delden C. et al., 2018/12. Transplant infectious disease, 20 (6) pp. e12984. Peer-reviewed.
 
The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. International immunopharmacology, 65 pp. 483-492. Peer-reviewed.
 
Use of Intraoperative Duplex Ultrasound and Resistance Index Reduces Complications in Living Renal Donor Transplantation.
Bejic M., Déglise S., Venetz J.P., Nseir G., Dubuis C., Saucy F., Berard X., Meuwly J.Y., Corpataux J.M., 2018/12. Transplantation proceedings, 50 (10) pp. 3192-3198. Peer-reviewed.
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction.
Juillerat-Jeanneret L., Aubert J.D., Mikulic J., Golshayan D., 2018/11/21. Journal of medicinal chemistry, 61 (22) pp. 9811-9840. Peer-reviewed.
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis.
Beckebaum S., Herzer K., Bauhofer A., Gelson W., De Simone P., de Man R., Engelmann C., Müllhaupt B., Vionnet J., Salizzoni M. et al., 2018/11/13. Annals of transplantation, 23 pp. 789-801. Peer-reviewed.
 
New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
Beckmann S., Denhaerynck K., Stampf S., Saigi-Morgui N., Binet I., Koller M., Boely E., De Geest S., Psychosocial Interest Group, Swiss Transplant Cohort Study, 2018/11. Transplant international, 31 (11) pp. 1254-1267. Peer-reviewed.
 
Efficient B cell Depletion With Rituximab Despite Massive Proteinuria.
Halfon M., Pascual M., Aubert V., Rotman S., Yannick M.D., 2018/10. Transplantation, 102 (10) pp. e401-e402. Peer-reviewed.
 
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
Mombelli M., Rettby N., Perreau M., Pascual M., Pantaleo G., Manuel O., 2018/10/01. Vaccine, 36 (41) pp. 6163-6169. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University